Daniel Aghion
Director, Oramed Pharmaceuticals.
Companies
- Oramed PharmaceuticalsBoard member Jan 2, 2024 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Oramed Pharmaceuticals ORMP113,441 shares2$462.8K at $4.08Dec 31, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Dec 31, 2025Granted 6,250 shares of Oramed Pharmaceuticals2
- Dec 31, 2025Granted 30,000 shares of Oramed Pharmaceuticals2
- Jun 5, 2025Granted 8,371 shares of Oramed Pharmaceuticals3
- Jun 5, 2025Granted 30,000 shares of Oramed Pharmaceuticals3
- Jan 30, 2024Granted 3,750 shares of Oramed Pharmaceuticals4
- Jan 4, 2024Granted 5,070 shares of Oramed Pharmaceuticals5
- Jan 4, 2024Granted 30,000 shares of Oramed Pharmaceuticals5
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGAROramed Pharmaceuticals, Board member
- 2
- 3SEC EDGARForm 4 filed Jun 9, 2025
- 4SEC EDGARForm 4 filed Jan 30, 2024
- 5SEC EDGARForm 4 filed Jan 8, 2024